199 related articles for article (PubMed ID: 28416445)
61. Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.
Yu R; Kompella SN; Adams DJ; Craik DJ; Kaas Q
J Med Chem; 2013 May; 56(9):3557-67. PubMed ID: 23566299
[TBL] [Abstract][Full Text] [Related]
62. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
[TBL] [Abstract][Full Text] [Related]
63. Synthesis and characterization of αM-conotoxin SIIID, a reversible human α7 nicotinic acetylcholine receptor antagonist.
Wang H; Li Y; Yang M; Zhou M
Toxicon; 2022 Apr; 210():141-147. PubMed ID: 35255330
[TBL] [Abstract][Full Text] [Related]
64. Alanine-Scanning Mutagenesis of α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor.
Ning J; Li R; Ren J; Zhangsun D; Zhu X; Wu Y; Luo S
Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30551685
[TBL] [Abstract][Full Text] [Related]
65. Stoichiometry dependent inhibition of rat α3β4 nicotinic acetylcholine receptor by the ribbon isomer of α-conotoxin AuIB.
Wu X; Tae HS; Huang YH; Adams DJ; Craik DJ; Kaas Q
Biochem Pharmacol; 2018 Sep; 155():288-297. PubMed ID: 30009767
[TBL] [Abstract][Full Text] [Related]
66. Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?
Nevin ST; Clark RJ; Klimis H; Christie MJ; Craik DJ; Adams DJ
Mol Pharmacol; 2007 Dec; 72(6):1406-10. PubMed ID: 17804600
[TBL] [Abstract][Full Text] [Related]
67. α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.
Hone AJ; Scadden M; Gajewiak J; Christensen S; Lindstrom J; McIntosh JM
Mol Pharmacol; 2012 Nov; 82(5):972-82. PubMed ID: 22914547
[TBL] [Abstract][Full Text] [Related]
68. Basic Residues at Position 11 of α-Conotoxin LvIA Influence Subtype Selectivity between α3β2 and α3β4 Nicotinic Receptors via an Electrostatic Mechanism.
Haufe Y; Kuruva V; Samanani Z; Lokaj G; Kamnesky G; Shadamarshan P; Shahoei R; Katz D; Sampson JM; Pusch M; Brik A; Nicke A; Leffler AE
ACS Chem Neurosci; 2023 Dec; 14(24):4311-4322. PubMed ID: 38051211
[TBL] [Abstract][Full Text] [Related]
69. Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels.
Daly NL; Callaghan B; Clark RJ; Nevin ST; Adams DJ; Craik DJ
J Biol Chem; 2011 Mar; 286(12):10233-7. PubMed ID: 21252227
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of cholinergic pathways in Drosophila melanogaster by α-conotoxins.
Heghinian MD; Mejia M; Adams DJ; Godenschwege TA; Marí F
FASEB J; 2015 Mar; 29(3):1011-8. PubMed ID: 25466886
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and characterization of 125I-alpha-conotoxin ArIB[V11L;V16A], a selective alpha7 nicotinic acetylcholine receptor antagonist.
Whiteaker P; Marks MJ; Christensen S; Dowell C; Collins AC; McIntosh JM
J Pharmacol Exp Ther; 2008 Jun; 325(3):910-9. PubMed ID: 18323456
[TBL] [Abstract][Full Text] [Related]
72. Acetylcholine promotes binding of α-conotoxin MII at α3 β2 nicotinic acetylcholine receptors.
Sambasivarao SV; Roberts J; Bharadwaj VS; Slingsby JG; Rohleder C; Mallory C; Groome JR; McDougal OM; Maupin CM
Chembiochem; 2014 Feb; 15(3):413-24. PubMed ID: 24420650
[TBL] [Abstract][Full Text] [Related]
73. Interaction of α9α10 Nicotinic Receptors With Peptides and Proteins From Animal Venoms.
Tsetlin V; Haufe Y; Safronova V; Serov D; Shadamarshan P; Son L; Shelukhina I; Kudryavtsev D; Kryukova E; Kasheverov I; Nicke A; Utkin Y
Front Cell Neurosci; 2021; 15():765541. PubMed ID: 35002625
[TBL] [Abstract][Full Text] [Related]
74. Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
Innocent N; Livingstone PD; Hone A; Kimura A; Young T; Whiteaker P; McIntosh JM; Wonnacott S
J Pharmacol Exp Ther; 2008 Nov; 327(2):529-37. PubMed ID: 18664588
[TBL] [Abstract][Full Text] [Related]
75. Conotoxin αD-GeXXA utilizes a novel strategy to antagonize nicotinic acetylcholine receptors.
Xu S; Zhang T; Kompella SN; Yan M; Lu A; Wang Y; Shao X; Chi C; Adams DJ; Ding J; Wang C
Sci Rep; 2015 Sep; 5():14261. PubMed ID: 26395518
[TBL] [Abstract][Full Text] [Related]
76. α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.
Hone AJ; McIntosh JM; Azam L; Lindstrom J; Lucero L; Whiteaker P; Passas J; Blázquez J; Albillos A
Mol Pharmacol; 2015 Nov; 88(5):881-93. PubMed ID: 26330550
[TBL] [Abstract][Full Text] [Related]
77. Novel αO-conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment.
Zhu X; Yuan M; Wang H; Zhangsun D; Yu G; Che J; Luo S
Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145535
[TBL] [Abstract][Full Text] [Related]
78. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism.
Gajewiak J; Christensen SB; Dowell C; Hararah F; Fisher F; Huynh PN; Olivera BM; McIntosh JM
J Med Chem; 2021 Jul; 64(13):9271-9278. PubMed ID: 34142837
[TBL] [Abstract][Full Text] [Related]
79. RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs.
Franco A; Kompella SN; Akondi KB; Melaun C; Daly NL; Luetje CW; Alewood PF; Craik DJ; Adams DJ; Marí F
Biochem Pharmacol; 2012 Feb; 83(3):419-26. PubMed ID: 22108175
[TBL] [Abstract][Full Text] [Related]
80. Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes.
Wang S; Zhao C; Liu Z; Wang X; Liu N; Du W; Dai Q
Mar Drugs; 2015 May; 13(6):3259-75. PubMed ID: 26023835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
